UPDATE 2-Healthcare platform Agilon targets valuation of up to $9 bln in U.S. IPO

(Adds background, financials)

April 7 (Reuters) - Agilon Health is aiming for a valuation of up to $9 billion in its initial public offering (IPO), the healthcare platform said on Wednesday, joining a clutch of companies looking to cash in on the record run in U.S. capital markets.

The company said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares at a price range of $20 and $23 per share.

Founded in 2016, Agilon is a healthcare platform that helps connect primary care physicians with patients who are mostly senior citizens. The company’s platform has around 210,000 patients enrolled in Medicare Advantage plans.

Medicare Advantage plans refer to the Medicare benefits that are offered to seniors and are administered by private insurance companies.

Private equity-backed Alignment Healthcare and Alphabet-backed Oscar Health Inc are other healthcare-focused companies that have also gone public recently, banking on the historic boom in U.S. IPO markets.

Companies raised $167 billion in 2020, according to data from Dealogic, a record that investment bankers expect will be surpassed this year thanks to a surge in listings of special purpose acquisition companies.

Agilon’s net loss attributable narrowed to $60 million last year, from a loss of $282.6 million in 2019. Revenue jumped 53% to $1.22 billion in 2020, while membership rose 45%.

The company will list on the New York Stock Exchange under the symbol “AGL,” it said in a filing.

JP Morgan, Goldman Sachs and BofA are among the underwriters for the offering. (Reporting by Niket Nishant and Mrinalika Roy in Bengaluru; Editing by Aditya Soni)